Ginkgo Bioworks Taps Transcriptic Robotics Software to Accelerate Automation

By Ken Briodagh October 11, 2017

Ginkgo Bioworks, the organism company, recently announced a collaboration with robotic cloud laboratory Transcriptic. Through the new five-year agreement, valued at more than $10 million, Ginkgo will incorporate Transcriptic's robotic automation software into its Boston-based foundries. The combined technologies are designed to bolster Ginkgo's automation capabilities and engineering capacity, strengthening its platform and cementing a foundation for continued growth.

Ginkgo's foundries currently rely on software and robotics to automate work on organism design across the flavor and fragrance, enzyme and agricultural industries. This collaboration builds upon Ginkgo's existing platform, bringing Transcriptic's unique expertise in flexible lab automation to supercharge designers' efficiency. Transcriptic's software integration will automate new parts of Ginkgo's experimental design process, adding greater flexibility and remote monitoring capabilities. With this collaboration, Ginkgo will double its current monthly foundry output, increase the speed and efficiency of product delivery to existing customers, and establish a flexible platform that can better scale to meet the needs of the ever-expanding biotech industry.

"Transcriptic's ability to translate organism designers' vision into reality via lab automation is unparalleled, and brings an unprecedented scale to our organism foundry," said Barry Canton, co-founder, Ginkgo Bioworks. "Transcriptic shares our vision of leveraging the power of technology to transform lab experiments for more efficiency and scale. Automating the right processes allows our team to spend more time on what they do best: thoughtful design, analysis and delivery, so that together we can meet the continued demand from industries rethinking manufacturing with biology."

This licensing agreement is the first of its kind for Transcriptic, and a significant expansion of its current business model. Transcriptic engineers will be on-premise at Ginkgo, working side by side with organism designers to improve efficiencies within Ginkgo's foundries and further enhance the software together.

"The Transcriptic platform automates laborious lab processes to make research faster, less expensive and increasingly scalable," said Yvonne Linney, CEO, Transcriptic. "We look forward to bringing our technology to Ginkgo—a company at the forefront of organism design—in a completely new way, and build the future of biotech together."


Ken Briodagh is a writer and editor with more than a decade of experience under his belt. He is in love with technology and if he had his druthers would beta test everything from shoe phones to flying cars.

Edited by Ken Briodagh


Original Page